Hostname: page-component-848d4c4894-mwx4w Total loading time: 0 Render date: 2024-06-24T14:31:43.248Z Has data issue: false hasContentIssue false

Bronchiolitis obliterans organising pneumonia secondary to tacrolimus toxicity in a pediatric cardiac transplant recipient

Published online by Cambridge University Press:  25 July 2022

Farida Karim*
Affiliation:
Department of Pediatrics, Ascension Sacred Heart Hospital, Pensacola, FL, USA
Amrit Misra
Affiliation:
Division of Cardiology, Children’s Hospital of Michigan, Department of Pediatrics, Central Michigan University College of Medicine, Detroit, MI 48201, USA
Swati Sehgal
Affiliation:
Division of Cardiology, Children’s Hospital of Michigan, Department of Pediatrics, Central Michigan University College of Medicine, Detroit, MI 48201, USA
*
Author for correspondence: Farida Karim, MD, Department of Pediatrics, Ascension Sacred Heart Hospital, Pensacola, University of Florida, USA. Tel: +1 832-762-1705. E-mail: farida.karimc@gmail.com

Abstract

Background:

Bronchiolitis obliterans organising pneumonia is a rare complication associated with calcineurin inhibitors and mammalian target of rapamycin inhibitors. While bronchiolitis obliterans organising pneumonia in adult transplant patients has been reported, it has not been well described in pediatric transplant patients.

Case description:

We present a case of a 19-month-old male patient with dilated cardiomyopathy who underwent orthotropic heart transplantation at 14 months of life for heart failure refractory to medical therapy. Approximately 4 months post-transplant, he presented with diarrhea and vomiting with acute kidney injury secondary to dehydration. His tacrolimus level on admission and first week of hospitalisation was within target range of 10–12 ng/ml. He was diagnosed with esophagitis and prescribed proton pump inhibitors. Our patient subsequently developed significant respiratory distress with initial chest radiograph showing right lower lobe opacities. Repeat tacrolimus at the time of worsening respiratory status was 84.2 ng/dL and his tacrolimus was held. He required intubation due to significant hypoxia with progression of lung to disease and development of diffuse bilateral opacities consistent with acute respiratory distress syndrome. Despite initiation of steroids and aggressive ventilator management, he continued to be hypoxic on maximal respiratory support. After 28 days post admission, support was withdrawn. On autopsy, his lung biopsy findings were consistent with bronchiolitis obliterans organising pneumonia.

Conclusion:

Life-threatening bronchiolitis obliterans organising pneumonia can be seen in pediatric transplant patients on tacrolimus or when transitioning from tacrolimus to sirolimus, highlighting the need for close monitoring of heart transplant patients on immunosuppressive medications presenting with hypoxia.

Keywords

Type
Brief Report
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Miwa, Y, Isozaki, T, Wakabayashi, K, et al. Tacrolimus-induced lung injury in a rheumatoid arthritis patient with interstitial pneumonitis. Modern Rheumatol Apr 2008; 18: 208211.CrossRefGoogle Scholar
Cunha, BA, Syed, U, Mickail, N. Renal transplant with bronchiolitis obliterans organizing pneumonia (BOOP) attributable to tacrolimus and herpes simplex virus (HSV) pneumonia. Heart Lung 2012 May 1; 41: 310315.CrossRefGoogle Scholar
Schmidt, RH, Lenz, T, Grone, HJ, Geiqur, H, Scheuermann, EH. Haemolytic-ureamic syndrome after tacrolimus rescue therapy for cortisone-resistant rejection. Nephrol Dial Transplant 1999; 14: 979983.CrossRefGoogle Scholar
Przepiorka, D, Abu-Elmagd, K, Huaringa, A, et al. Bronchiolitis obliterans oeganizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant 1993; 11: 502.Google Scholar
Lindenfeld, JA, Simon, SF, Zamora, MR, et al. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant 2005 Jun; 5: 13921396.CrossRefGoogle ScholarPubMed
Kelchtermans, J, Chang, J, Glaberson, W, DeFreitas, M, Alba-Sandoval, M, Chandar, J. A pediatric case of sirolimus-associated pneumonitis after kidney transplantation. J Pediatr Pharmacol Ther. 2020; 25: 459464.Google ScholarPubMed
Epler, GR. Bronchiolitis obliterans organizing pneumonia, 25 years: a variety of causes, but what are the treatment options? Expert Rev Respir Med 2011 Jun; 5: 353361. DOI 10.1586/ers.11.19.CrossRefGoogle Scholar
Dodd, JD, Müller, NL. Bronchiolitis obliterans organizing pneumonia after bone marrow transplantation: high-resolution computed tomography findings in 4 patients. J Comput Assist Tomo 2005 Jul 1; 29: 540543.CrossRefGoogle Scholar
Ishii, T, Manabe, A, Ebihara, Y, et al. Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin. Bone Marrow Transplant 2000 Oct; 26: 907910.CrossRefGoogle Scholar
Pascual, J, Marcén, R, Orea, OE, et al. Interaction between omeprazole and tacrolimus in renal allograft recipients: a clinical-analytical study. Transplant Proc 2005 Nov; 37: 37523753.CrossRefGoogle ScholarPubMed